Advertisement

Post-Thrombotic Syndrome

  • Devendra Dekiwadia
  • Birju Patel
  • Dilip Vaghasia
Chapter

Abstract

PTS may be considered as a postinflammatory stage of the venous system whereupon the venous tone and functioning of the valves of the veins are jeopardised. In the lower extremities, this results in deranged functions of the veins to perform antigravity venous drainage. Chronic venous congestion in the lower limbs ends into a large volume of deoxygenated blood stored in the veins. This results from poor performance of the venous pump capable of evacuating out the blood from the tissues. In superficial venous system derangements, varicose veins, the skin surface and the immediate deeper tissues mainly above the deep fascia are affected. When the entire system is affected, all the tissues of the limb are affected. Maybe the clinical manifestation could be of stasis ulcers, skin changes, varicose veins, etc., but at a depth all the tissues of the lower limb are affected. Age, infection, DVT, outflow obstruction and anomalous venous circulation are capable of chronic degenerative changes of the veins collectively called phlebosclerosis.

References

  1. 1.
    Prandoni P, Lensing A, Cogo A, Cuppini S, Villalta S, Carta M, Cattelan A, Polistena P, Bernardi E, Prins M. The longterm clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1–7.CrossRefGoogle Scholar
  2. 2.
    Stain M, Schonauer V, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Kyrle PA, Eichinger S. The postthrombotic syndrome: risk factors and impact on the course of thrombotic disease. J Thromb Haemost. 2005;3:2671–6.CrossRefGoogle Scholar
  3. 3.
    Schulman S, Lindmarker P, Holmstrom M, Larfars G, Carlsson A, Nicol P, Svensson E, Ljungberg B, Viering S, Nordlander S, Leijd B, Jahed K, Hjorth M, Linder O, Beckman M. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost. 2006;4:734–42.CrossRefGoogle Scholar
  4. 4.
    Kahn SR, Hirsch A, Shrier I. Effect of post-thrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med. 2002;162:1144–8.CrossRefGoogle Scholar
  5. 5.
    Bergqvist D, Jendteg S, Johansen L, Persson U, Odegaard K. Cost of long-term complications of deep venous thrombosis of the lower extremities: an analysis of a defined patient population in Sweden. Ann Intern Med. 1997;126:454–7.CrossRefGoogle Scholar
  6. 6.
    Kurz X, Kahn SR, Abenhaim L, Clement D, Norgren L, Bacaglini U, Berard A, Cooke JP, Cornu-Thenard A, Depairon M, Dormandy JA, Durand-Zaleski I, Fowkes GR, Lamping DL, Partsch H, Scurr JH, Zuccarelli F. Chronic venous disorders of the leg: epidemiology, outcomes, diagnosis and management - summary of an evidence-based report of the VEINES task force. Int Angiol. 1999;18:83–102.PubMedGoogle Scholar
  7. 7.
    Piovella F, Crippa L, Barone M, Vigano DS, Serafini S, Galli L, Beltrametti C, D’Angelo A. Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosis. Haematologica. 2002;87:515–22.PubMedGoogle Scholar
  8. 8.
    Roumen-Klappe E, der Heijer M, van Uum S, van der Ven-Jongekrijg J, van der Graaf F, Wollersheim H. Inflammatory response in the acute phase of deep vein thrombosis. J Vasc Surg. 2002;35:701–6.CrossRefGoogle Scholar
  9. 9.
    Milne AA, Stonebridge PA, Bradbury AW, Ruckley CV. Venous function and clinical outcome following deep vein thrombosis. Br J Surg. 1994;81:847–9.CrossRefGoogle Scholar
  10. 10.
    Kahn SR, Desmarais S, Ducruet T, Arsenault L, Ginsberg JS, VETO Study Investigators. Comparison of performance of two clinical scales to diagnose the post-thrombotic syndrome: correlation with patient-reported disease burden and valvular reflux. J Thromb Haemost. 2006;4:907–8.CrossRefGoogle Scholar
  11. 11.
    Villalta S, Bagatella P, Piccioli A, Lensing A, Prins M, Prandoni P. Assessment of validity and reproducibility of a clinical scale for the post-thrombotic syndrome (abstract). Haemostasis. 1994;158a:24.Google Scholar
  12. 12.
    Porter JM, Moneta GL, An International Consensus Committee on Chronic Venous Disease. Reporting standards in venous disease: an update. J Vasc Surg. 1995;21:635–45.CrossRefGoogle Scholar
  13. 13.
    Kolbach DN, Neumann HA, Prins MH. Definition of the post-thrombotic syndrome, differences between existing classifications. Eur J Vasc Endovasc Surg. 2005;30:404–14.CrossRefGoogle Scholar
  14. 14.
    Ginsberg JS, Gent M, Turkstra F, Buller HR, MacKinnon B, Magier D, Hirsh J. Postthrombotic syndrome after hip or knee arthroplasty. Arch Intern Med. 2000;160:669–72.Google Scholar
  15. 15.
    Prandoni P, Lensing AWA, Prins MH, Frulla M, Marchiori A, Bernardi E, Tormene D, Mosena L, Pagnan A, Girolami A. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med. 2004;141:249–56.CrossRefGoogle Scholar
  16. 16.
    Van Dongen CJ, Prandoni P, Frulla M, Marchiori A, Prins MH, Hutten BA. Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome. J Thromb Haemost. 2005;3:939–42.CrossRefGoogle Scholar
  17. 17.
    Kahn SR, Kearon C, Julian JA, MacKinnon B, Kovacs MJ, Wells P, Crowther MA, Anderson DR, Van Nguyen P, Demers C, Solymoss S, Kassis J, Geerts W, Rodger M, Hambleton J, Ginsberg JS. Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis. J Thromb Haemost. 2005;3:718–23.CrossRefGoogle Scholar
  18. 18.
    Lindner DJ, Edwards JM, Phinney ES, Taylor LM, Porter JM. Long-term hemodynamic and clinical sequelae of lower extremity deep vein thrombosis. J Vasc Surg. 1986;4:436–42.CrossRefGoogle Scholar
  19. 19.
    Monreal M, Martorell A, Callejas J, Valls R, Llamazares J, Lafoz E, Arias A. Venographic assessment of deep vein thrombosis and risk of developing post-thrombotic syndrome: a prospective study. J Intern Med. 1993;233:233–8.CrossRefGoogle Scholar
  20. 20.
    Browse NL, Clemenson G, Thomas ML. Is the postphlebitic leg always postphlebitic? Relation between postphlebitic phlebographic appearances of deep-vein thrombosis and late sequelae. BMJ. 1980;281:1167–70.CrossRefGoogle Scholar
  21. 21.
    Schulman S, Granqvist S, Juhlin-Dannfelt A, Lockner D. Long-term sequelae of calf vein thrombosis treated with heparin or low-dose streptokinase. Acta Med Scand. 1986;219:349–57.CrossRefGoogle Scholar
  22. 22.
    McLafferty RB, Moneta GL, Passman MA, Brant BM, Taylor LM Jr, Porter JM. Late clinical and hemodynamic sequelae of isolated calf vein thrombosis. J Vasc Surg. 1998;27:50–6.CrossRefGoogle Scholar
  23. 23.
    Wille-Jorgensen P, Jorgensen LN, Crawford M. Asymptomatic postoperative deep vein thrombosis and the development of postthrombotic syndrome. A systematic review and meta-analysis. Thromb Haemost. 2005;93:236–41.CrossRefGoogle Scholar
  24. 24.
    Schindler OS, Dalziel R. Post-thrombotic syndrome after total hip or knee arthroplasty: incidence in patients with asymptomatic deep venous thrombosis. J Orthop Surg (Hong Kong). 2005;13:113–9.CrossRefGoogle Scholar
  25. 25.
    Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: the Seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest. 2004;126:338S–400S.CrossRefGoogle Scholar
  26. 26.
    Cushman M, Folsom AR, Wang L, Aleksic N, Rosamond WD, Tracy RP, Heckbert SR. Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood. 2003;101:1243–8.CrossRefGoogle Scholar
  27. 27.
    Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ III. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158:585–93.CrossRefGoogle Scholar
  28. 28.
    Mohr DN, Silverstein MD, Heit JA, Petterson TM, O’Fallon WM, Melton LJ III. The venous stasis syndrome after deep venous thrombosis or pulmonary embolism: a population based study. Mayo Clin Proc. 2000;75:1249–56.CrossRefGoogle Scholar
  29. 29.
    Kahn SR, Ginsberg JS. Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med. 2004;164:17–26.CrossRefGoogle Scholar
  30. 30.
    Heit JA, Rooke TW, Silverstein MD, Mohr DN, Lohse CM, Petterson TM, O’Fallon M, Melton LJ III. Trends in the incidence of venous stasis syndrome and venous ulcer: a 25-year population-based study. J Vasc Surg. 2001;33:1022–7.CrossRefGoogle Scholar
  31. 31.
    Ramacciotti E, Gomes M, de Aguiar ET, Caiafa JS, de Moura LK, Araujo GR, Truzzi A, Dietrich-Neto F. A cost analysis of the treatment of patients with post-thrombotic syndrome in Brazil. Thromb Res. 2006;118:699.CrossRefGoogle Scholar
  32. 32.
    Harrison M, Graham I, Friedberg E, Lorimer K, Vandevelde-Coke S. Assessing the population with leg and foot ulcers. Can Nurse. 2001;97:18–23.PubMedGoogle Scholar
  33. 33.
    Phillips T, Stanton B, Provan A, Lew R. A study of the impact of leg ulcers on quality of life: financial, social, and psychologic implications. J Am Acad Dermatol. 1994;31:49–53.CrossRefGoogle Scholar
  34. 34.
    Kahn SR, M’Lan CE, Lamping DL, Kurz X, Be’rard A, Abenhaim L, VEINES Study Group. The influence of venous thromboembolism on quality of life and severity of chronic venous disease. J Thromb Haemost. 2004;2:2146–51.CrossRefGoogle Scholar
  35. 35.
    Kahn SR, Ducruet T, Lamping DL, Arsenault L, Miron MJ, Roussin A, Desmarais S, Joyal F, Kassis J, Solymoss S, Desjardins L, Johri M, Shrier I. Prospective evaluation of health-related quality of life in patients with deep venous thrombosis. Arch Intern Med. 2005;165:1173–8.CrossRefGoogle Scholar
  36. 36.
    Kahn SR, Panju A, Geerts W, Pineo GF, Desjardins L, Turpie AGG, Glezer S, Thabane L, Sebaldt RJ. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res. 2006;119:145.CrossRefGoogle Scholar
  37. 37.
    Kearon C. Long-term management of patients after venous thromboembolism. Circulation. 2004;110:I10–8.CrossRefGoogle Scholar
  38. 38.
    Davidson S. Davidson’s principles and practise of medicine. 16th ed. Edinburgh: Churchill Livingstone; 1991.Google Scholar
  39. 39.
    Goldhaber S, Buring J, Lipnick R, Hennekens C. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med. 1984;76:393–7.CrossRefGoogle Scholar
  40. 40.
    Wells P, Forster AJ. Thrombolysis in deep vein thrombosis: is there still an indication? Thromb Haemost. 2001;86:499–508.CrossRefGoogle Scholar
  41. 41.
    Elliot MS, Immelman EJ, Jeffery P, Benatar SR, Funston MR, Smith JA, Shepstone BJ, Ferguson AD, Jacobs P, Walker W, Louw JH. A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: an interim report of a prospective trial. Br J Surg. 1979;66:838–43.CrossRefGoogle Scholar
  42. 42.
    Arnesen H, Hoiseth A, Ly B. Streptokinase of heparin in the treatment of deep vein thrombosis. Follow-up results of a prospective study. Acta Med Scand. 1982;211:65–8.CrossRefGoogle Scholar
  43. 43.
    Turpie AG, Levine MN, Hirsh J, Ginsberg JS, Cruickshank MK, Jay RM, Gent M. Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Chest. 1990;97:172S–5S.PubMedGoogle Scholar
  44. 44.
    Comerota AJ, Throm RC, Mathias SD, Haughton S, Mewissen M. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg. 2000;32:130–7.CrossRefGoogle Scholar
  45. 45.
    Pierson S, Pierson D, Swallow R, Johnson GJ. Efficacy of graded elastic compression in the lower leg. JAMA. 1983;249:242–3.CrossRefGoogle Scholar
  46. 46.
    Brandjes DPM, Buller HR, Heijboer H, Hulsman MV, de Rijk M, Jagt H. Randomized trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet. 1997;349:759–62.CrossRefGoogle Scholar
  47. 47.
    Prandoni P. Elastic stockings, hydroxyethylrutosides or both for the treatment of post-thrombotic syndrome. Thromb Haemost. 2005;93:183–5.CrossRefGoogle Scholar
  48. 48.
    Appelen D, van Loo E, Prins MH, Neumann MH, Kolbach DN. Compression therapy for prevention of post-thrombotic syndrome. Cochrane Database Syst Rev. 2017;9:CD004174.  https://doi.org/10.1002/14651858.CD004174.pub3.CrossRefPubMedGoogle Scholar
  49. 49.
    Diehm C. Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency. Lancet. 1996;347:292–4.CrossRefGoogle Scholar
  50. 50.
    Prandoni P, Frulla M, Sartor D, Concolato A, Girolami A. Vein abnormalities and the post-thrombotic syndrome. J Thromb Haemost. 2005;3:401–2.CrossRefGoogle Scholar
  51. 51.
    Eklof BG, Kistner RL, Masuda EM. Venous bypass and valve reconstruction: long term efficacy. Vasc Med. 1998;3:157–64.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • Devendra Dekiwadia
    • 1
  • Birju Patel
    • 1
  • Dilip Vaghasia
    • 1
  1. 1.Dekiwadia HospitalRajkotIndia

Personalised recommendations